Amlitelimab (an anti-OX40 ligand antibody) Atopic Dermatitis (Eczema) Clinical Trial

Do you have Eczema?

OptiSkin is looking for healthy volunteers to join our paid clinical trials. Eligible volunteers with eczema will receive free biologic medication. Volunteer today and help pave the next generation of eczema treatments.

Duration

Study length is 42-44 weeks after enrollment. There are a total of 11 in-person visits required. Participants will be compensated for time and travel.

Study Specifics

For adult patients 18+ who have been diagnosed with moderate to severe eczema. Patients must be treated with Amlitelimab (an anti-OX40 ligand antibody) therapy once enrolled.

Eligibility

To participate, you MUST have:

  • Severe eczema

You will NOT be eligible if:

  • you have received Otezla® (apremilast) in the past
  • your child is currently enrolled in another clinical trial

Additional inclusion/exclusion criteria will apply.

Take Part In One Of Our Studies